DANIELS RONALD J 4
4 · BridgeBio Pharma, Inc. · Filed Dec 30, 2021
Insider Transaction Report
Form 4
DANIELS RONALD J
Director
Transactions
- Sale
Common Stock
2021-12-28$12.80/sh−11,745$150,336→ 0 total - Purchase
Common Stock
2021-12-28$12.73/sh+11,745$149,514→ 11,745 total - Purchase
Common Stock
2021-12-30$14.34/sh+10,402$149,165→ 10,402 total
Footnotes (3)
- [F1]The Reporting Person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of the purchase and sale of the Issuer's common stock on December 28, 2021 reported herein. The Reporting Person has agreed to voluntarily disgorge to the Issuer all short-swing profits realized by the Reporting Person from such transactions.
- [F2]Represents the weighted average sale price of the shares sold from $12.7275 to $12.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 2 and 3.
- [F3]Represents the weighted average sale price of the shares sold from $12.79 to $12.82 per share.